BMY vs EBC · P/E 17, rev $48.19B vs P/E 11, rev $75.8M
Bristol-Myers Squibb Company (BMY) versus Eastern Bankshares Inc (EBC) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Eastern Bankshares Inc (EBC) is a banks - regional company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported EBC revenue for 2026-06-30 was $75.8M. Net income was $170.5M. EBC currently screens at market cap $4.33B and trailing P/E 11.1.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. EBC currently screens at market cap $4.33B and trailing P/E 11.1.
Not investment advice. Open the BMY and EBC stock pages for the full models.
Not investment advice.